The research interests of this investigator center on acute and chronic heart failure, preventative cardiology, cardiovascular quality of care and outcomes, and implementing treatment systems to improve clinical outcome. published over 1400 research studies and clinical trials in heart failure, disease management, preventative cardiology, and outcomes research. New therapies and management strategies for advanced heart failure and research into the pathophysiology of this disease are conducted at UCLA under his direction. He has also developed and successfully implemented a comprehensive atherosclerosis treatment program at the UCLA Medical Center (Cardiovascular Hospitalization Atherosclerosis Management Program: CHAMP), which served as the model for the American Heart Association’s Get With The Guidelines Program. Dr Fonarow serves as PI for ADHERE, OPTIMIZE-HF, IMPROVE-HF, and CHAMP-HF performance improvement registries. He is on the steering committee or serves on the data safety monitoring committee for a number of ongoing randomized clinical trials in heart failure. Dr Fonarow is immediate past chair of the ACC/AHA Task Force for Performance Measures.